TotalPharma

Antwerpen ·KBO/BCE: BE 0797.048.802

Loading dossier…

Year closed	Due by	Filed	Variance	Reference
31-12-2025	31-07-2026	nothing on record	not filed	-
31-12-2024	31-07-2025	26-09-2025	57 d late	2025-00504769
31-12-2023	31-07-2024	27-08-2024	27 d late	2024-00375342

Line item	Code	2023
Balance sheet, Assets
TOTAL ASSETS	20/58	€218k
Fixed assets	21/28	€120k
Intangible fixed assets	21	€120k
Current assets	29/58	€98k
Amounts receivable within one year	40/41	€46k
Cash & bank	54/58	€53k
Balance sheet, Equity & liabilities
TOTAL EQUITY & LIABILITIES	10/49	€218k
Equity	10/15	€113k
Contributions / capital	10/11	€3k
Reserves	13	€110k
Amounts payable	17/49	€105k
Amounts payable within one year	42/48	€105k
Trade debts payable within one year	44	€35k
Income statement
Gross operating margin	9900	€207k
Operating result	9901	€147k
Financial income	75	€387
Financial charges	65	€374
Result before taxes	9903	€147k
Income taxes	67/77	€37k
Net result for the period	9904	€110k
Result to be appropriated	9905	€110k

Summary